Publication:
Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques

dc.contributor.authorDurdagi, Serdar
dc.contributor.authorSalmas, Ramin Ekhteiari
dc.contributor.authorStein, Matthias Jeanette
dc.contributor.authorYurtsever, Mine
dc.contributor.authorSeeman, Philip
dc.contributor.institutionDurdagi, Serdar, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.contributor.institutionSalmas, Ramin Ekhteiari, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey
dc.contributor.institutionStein, Matthias Jeanette, Molecular Simulations and Design Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
dc.contributor.institutionYurtsever, Mine, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey
dc.contributor.institutionSeeman, Philip, Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada
dc.date.accessioned2025-10-05T16:27:15Z
dc.date.issued2016
dc.description.abstractWe have recently reported G-protein coupled receptor (GPCR) model structures for the active and inactive states of the human dopamine D2 receptor (D2R) using adrenergic crystal structures as templates. Since the therapeutic concentrations of dopamine agonists that suppress the release of prolactin are the same as those that act at the high-affinity state of the D2 receptor (D2High), D2High in the anterior pituitary gland is considered to be the functional state of the receptor. In addition, the therapeutic concentrations of anti-Parkinson drugs are also related to the dissociation constants in the D2High form of the receptor. The discrimination between the high- And low-affinity (D2Low) components of the D2R is not obvious and requires advanced computer-assisted structural biology investigations. Therefore, in this work, the derived D2High and D2Low receptor models (GPCR monomer and dimer three-dimensional structures) are used as drug-binding targets to investigate binding interactions of dopamine and apomorphine. The study reveals a match between the experimental dissociation constants of dopamine and apomorphine at their high- And low-affinity sites of the D2 receptor in monomer and dimer and their calculated dissociation constants. The allosteric receptor-receptor interaction for dopamine D2R dimer is associated with the accessibility of adjacent residues of transmembrane region 4. The measured negative cooperativity between agonist ligand at dopamine D2 receptor is also correctly predicted using the D2R homodimerization model. © 2017 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1021/acschemneuro.5b00271
dc.identifier.endpage195
dc.identifier.issn19487193
dc.identifier.issue2
dc.identifier.pubmed26645629
dc.identifier.scopus2-s2.0-84959354684
dc.identifier.startpage185
dc.identifier.urihttps://doi.org/10.1021/acschemneuro.5b00271
dc.identifier.urihttps://hdl.handle.net/20.500.14719/12532
dc.identifier.volume7
dc.language.isoen
dc.publisherAmerican Chemical Society service@acs.org
dc.relation.sourceACS Chemical Neuroscience
dc.subject.authorkeywordsD2high And D2low States Of Dopamine
dc.subject.authorkeywordsDopamine D2 Receptor
dc.subject.authorkeywordsGpcr Dimerization
dc.subject.authorkeywordsMolecular Docking
dc.subject.authorkeywordsProtein Engineering
dc.subject.authorkeywordsApomorphine
dc.subject.authorkeywordsDopamine
dc.subject.authorkeywordsApomorphine
dc.subject.authorkeywordsDopamine
dc.subject.authorkeywordsDopamine Agonists
dc.subject.authorkeywordsReceptors, Dopamine D2
dc.subject.authorkeywordsApomorphine
dc.subject.authorkeywordsDimer
dc.subject.authorkeywordsDopamine
dc.subject.authorkeywordsDopamine 2 Receptor
dc.subject.authorkeywordsG Protein Coupled Receptor
dc.subject.authorkeywordsMonomer
dc.subject.authorkeywordsDopamine Receptor Stimulating Agent
dc.subject.authorkeywordsProtein Binding
dc.subject.authorkeywordsAllosterism
dc.subject.authorkeywordsArticle
dc.subject.authorkeywordsBinding Affinity
dc.subject.authorkeywordsChemical Structure
dc.subject.authorkeywordsDimerization
dc.subject.authorkeywordsDissociation Constant
dc.subject.authorkeywordsDrug Binding Site
dc.subject.authorkeywordsDrug Receptor Binding
dc.subject.authorkeywordsHydrogen Bond
dc.subject.authorkeywordsLigand Binding
dc.subject.authorkeywordsMolecular Docking
dc.subject.authorkeywordsPriority Journal
dc.subject.authorkeywordsProtein Engineering
dc.subject.authorkeywordsProtein Protein Interaction
dc.subject.authorkeywordsProtein Structure
dc.subject.authorkeywordsStereospecificity
dc.subject.authorkeywordsThree Dimensional Imaging
dc.subject.authorkeywordsBinding Competition
dc.subject.authorkeywordsChemistry
dc.subject.authorkeywordsDose Response
dc.subject.authorkeywordsDrug Effects
dc.subject.authorkeywordsHuman
dc.subject.authorkeywordsMetabolism
dc.subject.authorkeywordsMolecular Model
dc.subject.authorkeywordsProcedures
dc.subject.authorkeywordsApomorphine
dc.subject.authorkeywordsBinding, Competitive
dc.subject.authorkeywordsDopamine
dc.subject.authorkeywordsDopamine Agonists
dc.subject.authorkeywordsDose-response Relationship, Drug
dc.subject.authorkeywordsHumans
dc.subject.authorkeywordsModels, Molecular
dc.subject.authorkeywordsMolecular Docking Simulation
dc.subject.authorkeywordsProtein Binding
dc.subject.authorkeywordsProtein Engineering
dc.subject.authorkeywordsReceptors, Dopamine D2
dc.subject.indexkeywordsapomorphine
dc.subject.indexkeywordsdimer
dc.subject.indexkeywordsdopamine
dc.subject.indexkeywordsdopamine 2 receptor
dc.subject.indexkeywordsG protein coupled receptor
dc.subject.indexkeywordsmonomer
dc.subject.indexkeywordsdopamine receptor stimulating agent
dc.subject.indexkeywordsprotein binding
dc.subject.indexkeywordsallosterism
dc.subject.indexkeywordsArticle
dc.subject.indexkeywordsbinding affinity
dc.subject.indexkeywordschemical structure
dc.subject.indexkeywordsdimerization
dc.subject.indexkeywordsdissociation constant
dc.subject.indexkeywordsdrug binding site
dc.subject.indexkeywordsdrug receptor binding
dc.subject.indexkeywordshydrogen bond
dc.subject.indexkeywordsligand binding
dc.subject.indexkeywordsmolecular docking
dc.subject.indexkeywordspriority journal
dc.subject.indexkeywordsprotein engineering
dc.subject.indexkeywordsprotein protein interaction
dc.subject.indexkeywordsprotein structure
dc.subject.indexkeywordsstereospecificity
dc.subject.indexkeywordsthree dimensional imaging
dc.subject.indexkeywordsbinding competition
dc.subject.indexkeywordschemistry
dc.subject.indexkeywordsdose response
dc.subject.indexkeywordsdrug effects
dc.subject.indexkeywordshuman
dc.subject.indexkeywordsmetabolism
dc.subject.indexkeywordsmolecular model
dc.subject.indexkeywordsprocedures
dc.subject.indexkeywordsApomorphine
dc.subject.indexkeywordsBinding, Competitive
dc.subject.indexkeywordsDopamine
dc.subject.indexkeywordsDopamine Agonists
dc.subject.indexkeywordsDose-Response Relationship, Drug
dc.subject.indexkeywordsHumans
dc.subject.indexkeywordsModels, Molecular
dc.subject.indexkeywordsMolecular Docking Simulation
dc.subject.indexkeywordsProtein Binding
dc.subject.indexkeywordsProtein Engineering
dc.subject.indexkeywordsReceptors, Dopamine D2
dc.titleBinding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques
dc.typeArticle
dcterms.referencesAudet, Martin, Restructuring G-Protein- Coupled Receptor Activation, Cell, 151, 1, pp. 14-23, (2012), Dror, Ron O., Activation mechanism of the β 2-adrenergic receptor, Proceedings of the National Academy of Sciences of the United States of America, 108, 46, pp. 18684-18689, (2011), Rosenbaum, Daniel M., Structure and function of an irreversible agonist-β2 adrenoceptor complex, Nature, 469, 7329, pp. 236-242, (2011), McDonald, William M., Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors, Molecular and Cellular Endocrinology, 36, 3, pp. 201-209, (1984), George, Susan R., The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form, Endocrinology (United States), 117, 2, pp. 690-697, (1985), Seeman, Philip, Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors, Synapse, 61, 12, pp. 1013-1018, (2007), Seeman, Philip, Dopamine Receptor Parameters Detected by [3H]Spiperone Depend on Tissue Concentration: Analysis and Examples, Journal of Neurochemistry, 43, 1, pp. 221-235, (1984), Seeman, Philip, Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand, European Journal of Pharmacology - Molecular Pharmacology Section, 291, 2, pp. 59-66, (1995), Seeman, Philip, Dopamine D2 receptor binding sites for agonists: A tetrahedral model, Molecular Pharmacology, 28, 5, pp. 391-399, (1985), Seeman, Philip, Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography, Synapse, 49, 4, pp. 209-215, (2003)
dspace.entity.typePublication
local.indexed.atScopus
person.identifier.scopus-author-id22955598300
person.identifier.scopus-author-id56338023600
person.identifier.scopus-author-id7402996760
person.identifier.scopus-author-id56067383000
person.identifier.scopus-author-id36045322000

Files